Analyzing Healthcare

Host Roy Bejarano sits down with Dr. Yates Lennon, President of CHESS Health Solutions, to discuss the operational execution of value-based care (VBC) models, the complexities of ACO REACH, MSSP tracks, and risk-based agreements, and how health systems and provider groups can maximize performance in value-based contracts.

In this episode, Dr. Lennon breaks down how CHESS supports 220,000 lives, builds efficient care coordination teams, and negotiates value-based contracts with major payers. He also explores the challenges of aligning incentives, leveraging predictive analytics, and maintaining provider engagement. This is a must-listen for healthcare leaders, providers, and payers navigating the future of population health and risk-sharing agreements.

• [00:01]  Introduction to Dr. Yates Lennon and CHESS Health Solutions’ role in value-based care
• [02:25]  The scope of CHESS: 220,000 covered lives, ACO models, and payer agreements
• [12:28] The role of care coordination, clinical pharmacists, and social workers in reducing hospital readmissions
• [22:33]  How value-based contracts are negotiated and why aligning clinical and financial performance is crucial
• [40:47]  The rise of super practices vs. hospital systems – Who will win the future of physician market power?
• [50:16]  Specialty care integration & predictive analytics – What’s next for cost containment and clinical efficiency?

• Value-Based Care Requires Significant Infrastructure Investment – Managing 220,000+ lives demands a highly coordinated network of nurses, pharmacists, social workers, and analysts.
• Payer-Provider Collaboration is Critical – CHESS negotiates Medicare Advantage, MSSP, and commercial value-based agreements with major payers, ensuring contracts align with clinical capabilities.
• Super Practices Are Reshaping Physician Market Power – The rise of Privia, Oak Street, and Agilon is shifting influence away from hospital-owned physician groups, creating competition for high-risk patient populations.
• The Future Lies in Data-Driven Healthcare – Predictive and prescriptive analytics will define the next phase of value-based care, helping organizations prioritize patient outreach and interventions for maximum impact.

Website: CHESS Health Solutions

LinkedIn: Dr. Yates Lennon

Dr. Yates Lennon is the President of CHESS Health Solutions, a physician-led value-based care organization that partners with health systems, ACOs, and independent providers to implement risk-based care models. With a background in family medicine and health system leadership, he has helped CHESS become a turnkey provider of value-based care solutions, supporting operational transformation, clinical integration, and payer strategy.

Healthcare, Value-Based Care, Healthcare Trends, Roy Bejarano, Healthcare Innovations, ACOs, Risk-Based Contracts, Population Health, Care Coordination, Medicare Advantage, Payer-Provider Collaboration, Healthcare Leadership, Data-Driven Healthcare, Healthcare Economics, CHESS Health Solutions, Yates Lennon,

Host Roy Bejarano sits down with Amir Dan Rubin, an industry veteran and former CEO of One Medical, Stanford Health, UCLA Medical, and United Healthcare’s Optum. Now leading Healthier Capital, a venture fund dedicated to AI-driven healthcare innovations, Amir shares a holistic perspective on the intersection of technology, business strategy, and healthcare transformation.

This conversation explores how AI, value-based care, payer models, and care coordination must work together to drive sustainable innovation. Amir explains how AI can improve patient engagement and operational efficiency, but only when aligned with existing healthcare systems and incentives. He also delves into the challenges of scaling risk-based care models, the evolving role of health systems, and why execution is just as critical as strategy.

Timestamps:

Key Takeaways:

Resources:

Healthier Capital Website

LinkedIn

Amir Dan Rubin

is a distinguished healthcare executive renowned for his transformative leadership in innovative healthcare delivery. As the former CEO of One Medical, a membership-based primary care practice, Rubin spearheaded its national expansion, increased its membership base, and successfully led the company to a public offering in January 2020.

Rubin’s impressive career includes pivotal roles in leading healthcare organizations. He served as President and COO of UnitedHealth Group’s Optum and as CEO of Stanford Health Care, where he championed the integration of advanced technology and patient-centered care. His expertise lies in healthcare transformation, innovation, and leveraging digital tools to enhance patient experiences.

Rubin holds an MBA from Stanford University, an MHA from the University of Michigan, and a Bachelor’s degree in Economics from the University of California, Berkeley. His contributions have significantly impacted how healthcare organizations utilize technology to provide more accessible and patient-focused care.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, AI in Healthcare, Value-Based Care, Digital Health, Venture Capital in Healthcare, Health System Strategy,  Amir Dan Rubin, One Medical, Stanford Health, UCLA Medical, United Healthcare’s Optum, Holistic Healthcare,

Steven Meehan, Managing Director of Scale Life Sciences and Dr. Ya-El Mandel, Senior Vice President of Clinical Operations at Équilibre Biopharmaceuticals Corp., and the founder and CEO of Cardea Sciences, sit down to discuss the future of life sciences, clinical research, and healthcare investment. With a background in investment banking, clinical trials, and biotechnology operations, Steven shares insights into biotech funding trends, AI in life sciences, and private equity investment strategies in healthcare innovation.

The discussion takes a holistic approach to how the political and economic landscape impacts clinical research, why provider groups should enter the clinical trial space, and how private equity investors can optimize their life sciences investments.

• [00:00] Introduction to the podcast and guests, Steven Meehan & Dr. Ya-El Mandel
• [02:00] Steven’s background: From Wall Street to biotech investments and life sciences strategy
• [05:30] How private equity in healthcare is adapting to economic and political shifts
• [08:15] The impact of AI in healthcare and its role in clinical research & biotech advancements
• [11:00] The challenge of securing funding for small to mid-sized biotech firms
• [14:30] Why clinical trials are struggling with patient diversity and site participation
• [18:00] The opportunities for healthcare providers to integrate clinical research infrastructure
• [21:00] Final thoughts: The future of healthcare leadership, biotech investments, and AI in healthcare

• Private equity in healthcare is shifting toward strategic biotech investments. Investors are focusing on scalability, clinical research efficiency, and healthcare innovations.
• AI in healthcare is a transformative force. AI-driven healthcare trends are improving diagnostic accuracy, patient engagement, and operational efficiency.
• Diversity in clinical research is critical. Expanding patient recruitment beyond major institutions is essential for better healthcare industry insights and improved treatment outcomes.
• Healthcare leadership must integrate clinical research. Life sciences advancements depend on stronger partnerships between healthcare providers and biotech firms.

• Steven Meehan is an expert in biotech investments, private equity in healthcare, and life sciences advisory, with a background in investment banking and clinical research strategy.
• Dr. Ya-El Mandel specializes in clinical trial design, regulatory strategy, and healthcare innovations. She helps healthcare leadership and private equity navigate the complexities of clinical research.

Resources:

Scale Life Sciences Website

Steven Meehan

Website: [email protected] 

Steven’s Profilelinkedin.com/in/steven-meehan-776530

Dr. Ya-El Mandel 

Website: cardeasciences.com 

Linkedin: https://www.linkedin.com/in/yaelmp/overlay/contact-info/

Steven Meehan is a seasoned professional with over 25 years of expertise in financial and operational leadership, excelling in corporate strategy, mergers and acquisitions, capital raising, and financial planning and analysis. His extensive background demonstrates a strong focus on navigating organizations through complex financial and strategic challenges, with a keen emphasis on value creation and growth acceleration.

Ya-El Mandel, PhD, MSc, is a distinguished leader in biopharmaceuticals and medical innovation. As a founding member and Senior Vice President of Clinical Operations at Équilibre Biopharmaceuticals Corp., and the founder and CEO of Cardea Sciences, she spearheads advancements in non-invasive platforms for Atrial Fibrillation risk assessment. A PhD alumna of the Icahn School of Medicine at Mount Sinai, she also contributes as an adjunct professor. With over a decade of expertise in clinical trials and emergency medical leadership, Dr. Mandel’s work seamlessly integrates academia, industry, and healthcare innovation, driving transformative progress in the field.

: Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, Life Sciences, Clinical Research, AI in Healthcare, Private Equity in Healthcare, Biotech Investment, Steven Meehan, Scale Life Sciences, Dr. Ya-El Mandel, Équilibre Biopharmaceuticals Corp, Cardea Sciences,

Host Roy Bejarano speaks with Wyatt Ritchie, Managing Director at Cain Brothers, one of the leading investment banks specializing in healthcare transactions. Wyatt has overseen over 150 healthcare deals in the past five years and shares his expert insights on physician consolidation, private equity investment, and the changing healthcare services landscape.

This discussion takes a holistic approach to the future of healthcare investment, covering what works in MSOs, why physician practices must adapt, how AI will drive efficiencies, and how health systems and private equity are reshaping the landscape. Wyatt also addresses the evolution of capital markets, value-based care adoption, and the role of employer-sponsored healthcare innovation.

Timestamps:

• [00:00] Introduction to the podcast and guest, Wyatt Ritchie, Managing Director at Cain Brothers

• [02:00] Wyatt’s journey in healthcare investment banking: From Jeffries to Cain Brothers

• [06:30] The state of physician consolidation: Why private equity remains interested despite headwinds

• [12:00] Key investment trends: Which healthcare specialties are thriving, and which are struggling?

• [18:00] The rise of AI in healthcare and how it will drive operational efficiencies

• [24:30] Why health systems struggle with ambulatory care and what can be done

• [30:00] Multi-specialty vs. single-specialty MSOs: Which model is more sustainable?

• [40:00] Health system & MSO partnerships: A new wave of strategic alliances in healthcare

• [50:00] How private equity is adapting to a shifting capital environment

• [1:00:00] The future of employer-sponsored healthcare: Why companies are taking healthcare into their own hands

• Healthcare is entering a new phase of consolidation and efficiency. Physician groups must scale smarter by aligning with either health systems, private equity, or employer-driven healthcare innovations.

• Private equity investment in MSOs remains strong but is evolving. Investors are becoming more selective, prioritizing scalability, operational efficiency, and value-based care capabilities.

• AI will transform MSOs, health systems, and payer-provider relationships. AI is poised to drive efficiencies, reduce administrative waste, and enhance patient engagement, making it a key differentiator for future healthcare investment.

• Multi-specialty MSOs are gaining traction—but execution remains difficult. While multi-specialty models offer care coordination advantages, scaling them is far more complex than single-specialty roll-ups.

• Health system partnerships with MSOs are the next big wave. As hospitals face financial pressure, they are increasingly looking to partner with MSOs for ambulatory expansion, rather than owning all assets outright.

• Employer-driven healthcare is a growing force. Large corporations are moving away from traditional payer models, creating custom networks and engaging directly with provider groups to control costs and improve outcomes.

Connect with Wyatt Ritchie: Cain Brothers Website LinkedIn

Wyatt Ritchie is a healthcare investment banking leader with over 20 years of experience in M&A, private equity transactions, and strategic advisory for healthcare services. As Managing Director at Cain Brothers, Wyatt has played a pivotal role in helping healthcare organizations navigate consolidation, investment, and strategic growth.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, Physician Consolidation, Private Equity in Healthcare, MSO Growth, AI in Healthcare, Health System Partnerships, Wyatt Ritchie, Cain Brothers,

Steven Meehan, Managing Director of Scale Life Sciences and Dr. Ya-El Mandel, Senior Vice President of Clinical Operations at Équilibre Biopharmaceuticals Corp., and the founder and CEO of Cardea Sciences, sit down to discuss the future of life sciences, clinical research, and healthcare investment. With a background in investment banking, clinical trials, and biotechnology operations, Steven shares insights into biotech funding trends, AI in life sciences, and private equity investment strategies in healthcare innovation.

The discussion takes a holistic approach to how the political and economic landscape impacts clinical research, why provider groups should enter the clinical trial space, and how private equity investors can optimize their life sciences investments.

Timestamps:

• [00:00] Introduction to the podcast and guests, Steven Meehan & Dr. Ya-El Mandel

• [02:00] Steven’s background: From Wall Street to biotech investments and life sciences strategy

• [05:30] How private equity in healthcare is adapting to economic and political shifts

• [08:15] The impact of AI in healthcare and its role in clinical research & biotech advancements

• [11:00] The challenge of securing funding for small to mid-sized biotech firms

• [14:30] Why clinical trials are struggling with patient diversity and site participation

• [18:00] The opportunities for healthcare providers to integrate clinical research infrastructure

• Private equity in healthcare is shifting toward strategic biotech investments. Investors are focusing on scalability, clinical research efficiency, and healthcare innovations.

• AI in healthcare is a transformative force. AI-driven healthcare trends are improving diagnostic accuracy, patient engagement, and operational efficiency.

• Diversity in clinical research is critical. Expanding patient recruitment beyond major institutions is essential for better healthcare industry insights and improved treatment outcomes.

• Healthcare leadership must integrate clinical research. Life sciences advancements depend on stronger partnerships between healthcare providers and biotech firms.

• Steven Meehan is an expert in biotech investments, private equity in healthcare, and life sciences advisory, with a background in investment banking and clinical research strategy.

• Dr. Ya-El Mandel specializes in clinical trial design, regulatory strategy, and healthcare innovations. She helps healthcare leadership and private equity navigate the complexities of clinical research.

Resources:Scale Life Sciences Website

Steven Meehan

Website:[email protected] 

Steven’s Profilelinkedin.com/in/steven-meehan-776530

Dr. Ya-El Mandel 

Website:cardeasciences.com 

Linkedin:https://www.linkedin.com/in/yaelmp/overlay/contact-info/

About the Guests:
Steven Meehan is a seasoned professional with over 25 years of expertise in financial and operational leadership, excelling in corporate strategy, mergers and acquisitions, capital raising, and financial planning and analysis. His extensive background demonstrates a strong focus on navigating organizations through complex financial and strategic challenges, with a keen emphasis on value creation and growth acceleration.

Ya-El Mandel, PhD, MSc, is a distinguished leader in biopharmaceuticals and medical innovation. As a founding member and Senior Vice President of Clinical Operations at Équilibre Biopharmaceuticals Corp., and the founder and CEO of Cardea Sciences, she spearheads advancements in non-invasive platforms for Atrial Fibrillation risk assessment. A PhD alumna of the Icahn School of Medicine at Mount Sinai, she also contributes as an adjunct professor. With over a decade of expertise in clinical trials and emergency medical leadership, Dr. Mandel’s work seamlessly integrates academia, industry, and healthcare innovation, driving transformative progress in the field.

Host Roy Bejarano sits down with Jeff Staser, CFO of Straine Dental, to explore the evolving DSO market, the impact of private equity in healthcare, and the future of dental investments. As a dental industry veteran with decades of experience in scaling DSOs, optimizing financial models, and practice management, Jeff shares key insights on what makes Straine Dental’s ownership model unique, how hygiene departments drive revenue, and why data-driven decision-making is crucial for DSOs.

This episode covers the differences between Straine Dental and traditional DSOs, common mistakes dental practices make, and how AI in healthcare and DSOs will shape the future of the industry.

Timestamps:

• [00:00] Introduction to the podcast and guest, Jeff Staser, CFO of Straine Dental
• [02:00] Jeff’s background: From Heartland Dental to Straine Dental’s growth strategy
• [06:30] The origin of Straine Dental and its unique ownership structure
• [10:00] Why hygiene departments are a key driver of revenue for DSOs
• [14:30] How most independent dental practices fail to optimize operational efficiency
• [18:00] The role of private equity in shaping the future of DSOs
• [22:30] The importance of KPIs and analytics in DSO success
• [26:00] How AI and technology are changing the DSO landscape
• [30:30] The biggest challenges and resistance dentists face when scaling their practices
• [35:00] Jeff’s predictions for the future of DSOs and dental consolidation trends
• [40:00] Final thoughts and closing remarks

Key Takeaways:

• Straine Dental prioritizes dentist ownership in its DSO model. Unlike traditional private equity-backed DSOs, Straine ensures that clinicians maintain majority ownership, aligning incentives for long-term practice growth.

• Hygiene departments are a hidden driver of DSO success. Many dental practices underinvest in hygiene, missing out on significant revenue opportunities that could improve patient care and practice performance.

• Private equity in healthcare is accelerating DSO consolidation. Large DSOs are focusing on de novo growth instead of acquisitions, leading to fewer opportunities for individual dentists to sell their practices in the future.

• The future of the DSO market will resemble healthcare systems. Larger dental groups will increasingly adopt medical-like structures, integrating technology, data-driven management, and operational efficiencies.

Website-https://dykemadso.com/

LinkedIn-https://www.linkedin.com/in/jeff-staser-0530a71a/

About Jeff Staser:

Jeff Staseris the CFO of prominent dental practice management firm Straine. With his vast experience and knowledge in the industry, Jeff Staser has provided valuable insights into the current trends and challenges faced by DSOs.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, Private Equity in Healthcare, Dental Support Organizations (DSOs), Dental Investments, AI in Healthcare, Jeff Staser, Straine Dental,

Host Roy Bejarano sits down with Jason Tushman, CEO of Red Spot Interactive, to discuss the challenges of healthcare IT adoption, patient acquisition, and digital marketing. With over 15 years of experience in healthcare marketing, CRM, and practice management solutions, Jason shares insights into why healthcare IT lags behind other industries, how data integration can improve patient retention, and why AI and predictive analytics are the future of healthcare marketing.

This episode explores why most healthcare practices struggle with digital transformation, the biggest inefficiencies in patient communication, and how CRM technology is reshaping practice operations. Jason also reveals the most cost-effective digital marketing strategies for healthcare providers and how AI in healthcare will drive automation and operational efficiencies.

Timestamps:

• [00:00] Introduction to the podcast and guest, Jason Tushman, CEO of Red Spot Interactive
• [02:00] Jason’s background: How his experience in automotive finance led to healthcare IT
• [06:00] The early challenges of Red Spot Interactive and the pivot into patient acquisition
• [10:00] The biggest reasons healthcare IT adoption lags behind other industries
• [14:30] How data fragmentation is slowing down digital transformation in healthcare
• [18:00] Why healthcare marketing remains inefficient and how CRM can fix it
• [22:00] How AI in healthcare will change patient acquisition & operational workflows
• [26:30] The importance of integrating call centers with practice management systems
• [30:00] Why standardized data is essential for healthcare system-wide efficiency
• [35:00] The future of patient engagement: AI, predictive analytics, and automation
• [40:00] Final thoughts and predictions for the next five years in healthcare IT

Key Takeaways:

• Healthcare IT adoption lags due to fragmented data and misaligned decision-makers. Most practices fail to integrate data across phone systems, practice management software, and marketing platforms, creating inefficiencies.

• AI in healthcare will drive automation and improve patient retention. AI-powered patient engagement, automated scheduling, and predictive analytics will increase efficiency and reduce administrative burdens.

• CRM is the missing link between patient acquisition, retention, and revenue tracking. A properly integrated CRM allows practices to connect marketing efforts to real patient outcomes and revenue performance.

• Organic video content is the most cost-effective healthcare marketing strategy. Practices that invest in educational video content on social media, YouTube, and their websites see the highest ROI on marketing efforts.

• Red Spot Interactive Websitehttps://www.redspotinteractive.com/

• LinkedIn: Jason Tushmanhttps://www.linkedin.com/in/jason-tuschman/

  
  

Jason Tushman is the CEO and Founder of Red Spot Interactive, a leading healthcare CRM and patient acquisition platform. With over 15 years of experience in healthcare IT and marketing, Jason specializes in helping multi-location practices streamline patient engagement, optimize digital marketing, and improve operational efficiency through AI and data integration.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, Private Equity in Healthcare, AI in Healthcare, Patient Acquisition, Digital Marketing in Healthcare, CRM for Healthcare, Jason Tushman, Red Spot Interactive,

Host Roy Bejarano sits down with Scott Herman, CEO of New Day Healthcare, to discuss how home healthcare is evolving, the challenges of scaling a home care platform, and how AI is transforming care delivery. New Day Healthcare, founded in 2020, has rapidly grown to 120,000 patients, 7,000 team members, and 29 locations across five states, making it one of the fastest-growing home health providers in the industry.

In this episode, Scott shares insights into the importance of technology-driven home care models, how New Day differentiates itself from traditional home care providers, and why AI-driven analytics are crucial for improving patient outcomes. He also explains how Medicare Advantage is reshaping home care, why avoiding the acquisition "value trap" is essential, and how his company is pioneering a virtual-first home healthcare model.

Timestamps:

• [00:00] Introduction to the podcast and guest, Scott Herman, CEO of New Day Healthcare
• [02:00] Scott’s background: From paramedic and nurse to leading major home health platforms
• [06:00] How New Day Healthcare differs from traditional home care providers
• [10:00] Why a virtual-first corporate model reduces overhead and improves patient care
• [14:30] How New Day avoids the acquisition "value trap" when scaling
• [18:00] The role of AI in healthcare: How New Day uses predictive analytics to manage patient care
• [22:00] Why Medicare Advantage is driving major change in home healthcare
• [26:30] The challenges of integrating different EMRs and billing systems
• [30:00] How AI-driven automation is streamlining patient referrals and intake
• [35:00] The future of home healthcare: AI, predictive analytics, and strategic partnerships
• [40:00] Final thoughts and Scott’s predictions for the future of the home care industry

Key Takeaways:

• New Day Healthcare is revolutionizing home care with a virtual-first model. By eliminating corporate overhead and using AI-powered automation, New Day is able to deliver more resources to bedside care.

• AI in healthcare is transforming home health operations. Predictive analytics, AI-driven patient tracking, and automated referral processing are helping New Day reduce hospitalizations and improve patient engagement.

• Avoiding the "value trap" in acquisitions is key to sustainable growth. Unlike other home care providers, New Day focuses on middle-tier acquisitions and leverages AI to optimize operations instead of overpaying for premium assets.

• Medicare Advantage is forcing home health providers to rethink their business models. With 53% of Medicare patients now enrolled in MA plans, New Day is adapting to lower-margin, high-volume care models.

• Strategic partnerships must be carefully structured. Scott explains why many home care providers fall into inefficient strategic alliances and how New Day selectively engages in payer and provider partnerships.

• New Day Healthcare Websitehttps://www.newdayhealthcare.com/

• LinkedIn: Scott Hermanhttps://www.linkedin.com/in/g-scott-herman-10a9a1178/

  
  

Scott Herman is a home healthcare industry leader with over 30 years of experience in scaling home health, hospice, and personal care platforms. As the CEO of New Day Healthcare, Scott has built one of the fastest-growing tech-enabled home care companies in the U.S., focused on AI-driven care delivery and operational efficiency.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, Private Equity in Healthcare, Home Healthcare, AI in Healthcare, Medicare Advantage, Patient Acquisition, Scott Herman, New Day Healthcare,

Host Roy Bejarano sits down with Jason Conger and Dr. Marlow Hernandez, co-founders of Soran Health, to discuss how healthcare innovations are reshaping value-based care. They explore the challenges of public ownership in healthcare, the importance of payer-provider partnerships, and how data-driven insights can improve patient outcomes.

In this episode, Jason and Marlow share their healthcare industry insights from their time at Cano Health to launching Soran Health, explaining how their experiences in healthcare leadership shaped their mission to transform specialty care services at home.

• [00:01] Introduction to the podcast and guests, Jason Conger & Dr. Marlow Hernandez
• [04:15] Public ownership in healthcare: Pros, cons, and lessons from Cano Health
• [09:45] How provider incentives impact healthcare industry performance
• [15:30] The power of payer-provider partnerships in healthcare leadership
• [22:00] Geographic expansion in healthcare: Lessons from scaling Cano Health
• [30:00] The foundation of Soran Health: A new approach to value-based care
• [38:30] How predictive analytics & real-time healthcare insights drive better patient care
• [45:00] The future of healthcare: Innovations, partnerships, and technology-driven solutions

• Public Ownership in Healthcare Requires Strategic Planning: Healthcare leadership teams must have a strong capital base and operational infrastructure before considering an IPO.
• Payer-Provider Partnerships Are Essential for Value-Based Care: Collaborations like those with Humana have proven that healthcare innovations can drive better patient outcomes while managing costs.
• Soran Health is Pioneering a New Model in Specialty Care: By leveraging healthcare data analytics, Soran Health is improving care delivery without relying on traditional claims data.
• Predictive Analytics is the Future of Healthcare Trends: Instead of waiting for claims or medical deterioration, real-time risk stratification can proactively improve patient outcomes.

• Soran Health Website: https://www.soranhealth.org/
• LinkedIn: Dr. Marlow Hernandez: linkedin.com/in/marlowhernandez

Jason Conger

Jason R. R. Conger is an American attorney and Republican politician from the U.S. state of Oregon. He served in the Oregon House of Representatives representing District 54 in Bend, Oregon, from 2011 to 2015.

Marlow Hernandez

Marlow Hernandez, D.O. is a board-certified physician and experienced venous specialist who has been serving the South Florida community for more than a decade.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, Payer-Provider Partnerships, Value-Based Care, Public Healthcare Ownership, Healthcare Data Analytics, Public Ownership, Payer-Provider Partnership Models, and the Evolution of Value-Based Care, Jason Conger, Dr. Marlow Hernandez, Soran Health,

Host Roy Bejarano sits down with Jason Conger and Dr. Marlow Hernandez, co-founders of Soran Health, to discuss how healthcare innovations are reshaping value-based care. They explore the challenges of public ownership in healthcare, the importance of payer-provider partnerships, and how data-driven insights can improve patient outcomes.

In this episode, Jason and Marlow share their healthcare industry insights from their time at Cano Health to launching Soran Health, explaining how their experiences in healthcare leadership shaped their mission to transform specialty care services at home.

Timestamps:

• [00:01] Introduction to the podcast and guests, Jason Conger & Dr. Marlow Hernandez
• [04:15] Public ownership in healthcare: Pros, cons, and lessons from Cano Health
• [09:45] How provider incentives impact healthcare industry performance
• [15:30] The power of payer-provider partnerships in healthcare leadership
• [22:00] Geographic expansion in healthcare: Lessons from scaling Cano Health
• [30:00] The foundation of Soran Health: A new approach to value-based care
• [38:30] How predictive analytics & real-time healthcare insights drive better patient care
• [45:00] The future of healthcare: Innovations, partnerships, and technology-driven solutions

Key Takeaways:

• Public Ownership in Healthcare Requires Strategic Planning: Healthcare leadership teams must have a strong capital base and operational infrastructure before considering an IPO.
• Payer-Provider Partnerships Are Essential for Value-Based Care: Collaborations like those with Humana have proven that healthcare innovations can drive better patient outcomes while managing costs.
• Soran Health is Pioneering a New Model in Specialty Care: By leveraging healthcare data analytics, Soran Health is improving care delivery without relying on traditional claims data.
• Predictive Analytics is the Future of Healthcare Trends: Instead of waiting for claims or medical deterioration, real-time risk stratification can proactively improve patient outcomes.

• Soran Health Website:https://www.soranhealth.org/
• LinkedIn: Dr. Marlow Hernandez:linkedin.com/in/marlowhernandez

Jason Conger

Jason R. R. Conger is an American attorney and Republican politician from the U.S. state of Oregon. He served in the Oregon House of Representatives representing District 54 in Bend, Oregon, from 2011 to 2015.

Marlow Hernandez

Marlow Hernandez, D.O. is a board-certified physician and experienced venous specialist who has been serving the South Florida community for more than a decade.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, Payer-Provider Partnerships, Value-Based Care, Public Healthcare Ownership, Healthcare Data Analytics, Public Ownership, Payer-Provider Partnership Models, and the Evolution of Value-Based Care, Jason Conger, Dr. Marlow Hernandez, Soran Health,